Examkin

Question

Difficulty: MediumReproductive Endocrinology and Infertility

Match each of the following clinical scenarios describing patients presenting for fertility evaluation to the most appropriate primary therapeutic intervention or assisted reproductive technology.

  • A patient with a body mass index of 33 kg/m², oligomenorrhea, and clinical hyperandrogenism who has patent fallopian tubes and a partner with normal semen parameters.Ovulation induction with letrozole
  • A patient with regular menstrual cycles and a history of recurrent pelvic inflammatory disease leading to bilateral distal tubal occlusion, whose partner has normal semen parameters.Standard in vitro fertilization (IVF)
  • A patient with normal ovulation and pelvic anatomy whose partner's semen analysis reveals a concentration of 1.5 million/mL, 15% progressive motility, and 2% normal morphology.Intracytoplasmic sperm injection (ICSI)
  • A patient presenting with a 14-month history of secondary amenorrhea, vasomotor symptoms, and a serum follicle-stimulating hormone level of 78 mIU/mL.In vitro fertilization with donor oocytes

Answer

The patient with PCOS should receive letrozole; the patient with tubal occlusion should undergo standard IVF; the patient whose partner has severe male factor infertility should undergo ICSI; and the patient with primary ovarian insufficiency should use donor oocyte IVF.
Therapeutic strategies for infertility are highly specific to the underlying pathology. Ovulation induction is indicated for WHO Group II anovulation (e.g., PCOS). Standard IVF is the primary treatment for uncorrectable tubal factor. ICSI is specifically designed to overcome severe male factor deficits. Donor oocytes are required when the patient's own ovarian reserve is exhausted (e.g., primary ovarian insufficiency).

Step-by-Step Solution

1
Analyze the etiology of infertility for the first patient.
The combination of obesity, oligomenorrhea, and hyperandrogenism diagnoses Polycystic Ovary Syndrome (PCOS).
Determining that ovulation failure is the sole barrier directs therapy toward ovulation induction.
2
Select the appropriate intervention for PCOS.
Letrozole is matched to the first patient.
Letrozole is the first-line evidence-based medication for ovulation induction in PCOS.
3
Analyze the etiology for the second patient.
The patient has structural tubal factor infertility (bilateral distal occlusion).
Anatomical barriers prevent the natural meeting of sperm and oocyte.
4
Select the appropriate intervention for severe tubal disease.
Standard in vitro fertilization (IVF) is matched to the second patient.
IVF bypasses the fallopian tubes by extracting oocytes, fertilizing them in vitro, and transferring embryos directly into the uterus.
5
Analyze the etiology for the third patient.
The infertility is driven by severe male factor (oligoasthenoteratozoospermia).
Sperm quantity and quality are insufficient for natural fertilization or even standard IVF.
6
Select the appropriate intervention for severe male factor.
Intracytoplasmic sperm injection (ICSI) is matched to the third patient.
ICSI mechanically assists fertilization by injecting a single viable sperm directly into the oocyte.
7
Analyze the etiology for the fourth patient.
Elevated FSH and amenorrhea signify primary ovarian insufficiency.
The ovaries no longer contain a functional follicular reserve.
8
Select the appropriate intervention for depleted ovarian reserve.
In vitro fertilization with donor oocytes is matched to the fourth patient.
Pregnancy requires an exogenous source of healthy oocytes.

Key Concept

Selecting the most appropriate assisted reproductive technology or pharmacological intervention based on the specific underlying etiology of infertility (PCOS, tubal factor, male factor, or primary ovarian insufficiency).
Estimated Time:1m 30s
Rate this question

Topics

Reproductive Endocrinology and Infertility

More questions from this topic